<< Back to the abstract archive
Single Surgeon 6-year Evolution with Biosynthetic Soft Tissue Support in Internal Bra Mastopexy and Reduction
Kelly C. Ho, BS1
Peter F. Koltz, MD2,3
1. Chicago Medical School at Rosalind Franklin University of Medicine & Science, Chicago, IL, 60064,
2025-01-09
Presenter: Kelly Ho, BS
Affidavit:
Kelly Ho
Director Name: Dr. Peter F. Koltz
Author Category: Medical Student
Presentation Category: Clinical
Abstract Category: Breast (Aesthetic and Recon.)
BACKGROUND:
Mastopexy, breast reduction, and oncoplastic procedures have similar goals including re-shaping, tightening, and repositioning the nipple-areola complex (NAC) and breast mound. Breast skin and soft tissue have variables which threaten ideal proportions, symmetry, and upper pole volume over time. Soft tissue support with biosynthetic meshes have been reported. A single surgeon experience with 3 popular meshes over the past 6 years are reported here to determine relative safety and efficacy.
METHODS:
A retrospective review of all mastopexy, breast reduction, and oncoplastic procedures performed with biosynthetic meshes performed from January 1, 2018 to April 1, 2024. Descriptive statistics were used to analyze the cohort.
RESULTS:
376 patients (752 breasts) met inclusion criteria over the study period. 52 patients underwent mastopexy, 182 underwent reduction mammoplasty, and 142 underwent oncoplastic procedures. Median follow-up was 1062 days (range 185-2166 days). Median age was 48 years (22-74 years). P4HB (galaflex), PDO(Durasob), and PLLA/PGA(Tigr) were used in 22, 186, and 168 patients respectively. Average BMI, resection weights, and medical comorbidities were not significantly different between mesh groups. Infection and need for cosmetic revision were not significantly different between groups. Mesh exposure and need for repeat debridement was significantly less common in Tigr group. Need for re-operation for asymmetry or recurrent ptosis was infrequent.
CONCLUSION:
Biosynthetic meshes in mastopexy techniques are well-described as safe and effective. The largest single surgeon experience with the most common biosynthetic meshes is reported here to demonstrate relative safety and efficacy in techniques growing in popularity.
